Gerald S. Lipshutz

General Surgery
200 Medical Plz
Los Angeles, CA 90095

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications

A hybrid piggyBac AAV-transposon and LNP-transposase for treating arginase deficiency: A 100-fold dose reduction compared to AAV alone.

A hybrid piggyBac AAV-transposon and LNP-transposase for treating arginase deficiency: A 100-fold dose reduction compared to AAV alone.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: December 07, 2025

Guanidino compounds with native GABA(A) δ receptor selectivity: a tale of homeostatic compensation in δ-KO mice.

Guanidino compounds with native GABA(A) δ receptor selectivity: a tale of homeostatic compensation in δ-KO mice.

Journal: BMC neuroscience
Published: September 03, 2025

Evaluation of SLC6A8 species conservation and the effect of pathogenic variants on creatine transport.

Evaluation of SLC6A8 species conservation and the effect of pathogenic variants on creatine transport.

Journal: HGG advances
Published: April 06, 2025

A hypomorphic model of CPS1 deficiency for investigating the effects of hyperammonemia on the developing nervous system.

A hypomorphic model of CPS1 deficiency for investigating the effects of hyperammonemia on the developing nervous system.

Journal: Disease models & mechanisms
Published: January 25, 2025

Establishing a core outcome set for creatine transporter deficiency and guanidinoacetate methyltransferase deficiency.

Establishing a core outcome set for creatine transporter deficiency and guanidinoacetate methyltransferase deficiency.

Journal: Orphanet journal of rare diseases
Published: December 06, 2024

[18F]FDG-PET and [18F]MPPF-PET are brain biomarkers for the creatine transporter Slc6a8 loss of function mutation.

[18F]FDG-PET and [18F]MPPF-PET are brain biomarkers for the creatine transporter Slc6a8 loss of function mutation.

Journal: Scientific reports
Published: December 04, 2024

Establishing a Core Outcome Set for Creatine Transporter Deficiency and Guanidinoacetate Methyltransferase Deficiency.

Establishing a Core Outcome Set for Creatine Transporter Deficiency and Guanidinoacetate Methyltransferase Deficiency.

Journal: medRxiv : the preprint server for health sciences
Published: October 07, 2024

Use of an oversized AAV8 vector for CPS1 deficiency results in long-term survival and ammonia control.

Use of an oversized AAV8 vector for CPS1 deficiency results in long-term survival and ammonia control.

Journal: Molecular therapy. Nucleic acids
Published: August 08, 2024

Staying on target in gene and cell therapy.

Staying on target in gene and cell therapy.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: August 06, 2024

Recent developments in translational imaging of in vivo gene therapy outcomes.

Recent developments in translational imaging of in vivo gene therapy outcomes.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: July 31, 2024

A2/A2B Deceased Donor Kidney Transplantation Using A2 Titers Improves Access to Kidney Transplantation: A Single-Center Study.

A2/A2B Deceased Donor Kidney Transplantation Using A2 Titers Improves Access to Kidney Transplantation: A Single-Center Study.

Journal: Kidney medicine
Published: July 01, 2024

Publisher Correction: Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia.

Publisher Correction: Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia.

Journal: Nature
Published: June 06, 2024
Showing 1-12 of 60

Last Updated: 09/26/2026